IDWeek 2020

Special Presentation

COVID-19 Clinical Trial

Conducting Clinical Trial within a Physician Private Practice

Ramesh V. Nathan, MD, Infectious Disese Specialist

Presented Live on Friday, October 23, 2020
1:00 – 1:15 p.m. ET and 2:00 – 2:15 p.m. ET

View recording of the presentation
To speak with a Healix Representative now about our services, join a live Zoom call: Live Zoom Call

About the Presentation

While attending IDWeek 2020, visit the Healix virtual booth to hear from Dr. Ramesh V. Nathan, a Healix client and a primary investigator of COVID-19 clinical trials through his office infusion center. Dr. Nathan will be presenting on, “COVID-19 Clinical Trial: Conducting Clinical Research Within a Physician Private Practice.”

About Ramesh V. Nathan, MD

Dr. Ramesh Nathan, MD, is a infectious disease specialist in Thousand Oaks, CA, and has over 20 years of experience in the medical field. He currently practices at Mazur, Nathan, Statner, Dutta, MDs, and is affiliated with Los Robles Regional Medical Center. Dr. Nathan graduated from George Washington University / School of Medicine And Health Sciences medical school in 2000 and is board certified in Infectious Disease.

Healix-Sponsored Research at IDWeek^TM 2020

From our long-standing involvement in the infectious disease community, Healix also coordinates and conducts collaborative clinical research in the provision of Outpatient Parenteral Antimicrobial Therapy (OPAT) since 2008. While attending the conference, please visit the following Healix-sponsored poster presentations with presenter audio available beginning October 21 in the IDWeek^TM ePoster Gallery:

#614: Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics

Brian S. Metzger, MD, MPH¹, Richard C. Prokesch, MD, FACP, FIDSA², Jorge R. Bernett, MD³, Richard M. Mandel, MD⁴, FIDSA, Ramesh V. Nathan, MD, FIDSA⁵, Kent J. Stock, DO⁶, Thomas C. Hardin, PharmD⁷, Claudia P. Schroeder, PharmD, PhD⁷, Lucinda J. Van Anglen, BS, PharmD⁷

¹Austin Infectious Disease Consultants, Austin, TX; ²Infectious Disease Associates, Riverdale, GA; ³Infectious Disease Doctors Medical Group, Walnut Creek, CA; ⁴Southern Arizona Infectious Disease Specialists, Tucson, AZ; ⁵Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA; ⁶Low Country Infectious Disease, Summerville, SC; ⁷Healix Infusion Therapy, Sugar Land, TX

#787: Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients and non-C. difficile Patients in Outpatient Infusion Centers

Kevin W. Garey, PharmD¹, Richard L. Hengel, MD², Timothy E. Ritter, MD³, Ramesh V. Nathan, MD, FIDSA⁴, Claudia P. Schroeder, PharmD, PhD⁵, Gabriella Costa¹, Chris Lancaster¹, Engels N. Obi⁶, Lucinda J. Van Anglen, BS, PharmD⁵

¹University of Houston College of Pharmacy, Houston, TX; ²Atlanta ID Group, Atlanta, GA; ³GI Alliance, Southlake, TX; ⁴Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA; ⁵Healix Infusion Therapy, Sugar Land, TX; ⁶Merck & Co, Inc., Kenilworth, NJ

#1327: Vancomycin Dosing by AUC₂₄/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)

Quyen Luu, MD¹, John S. Adams, MD, FIDSA, FSHEA², Brian S. Metzger, MD, MPH³, Richard L. Hengel, MD⁴, Rishi Bhattacharyya, MD⁵, David N. Rhoads, PharmD⁶, Kimberly A. Couch, PharmD⁶; Claudia P. Schroeder, PharmD, PhD⁶; Lucinda J. Van Anglen, BS, PharmD⁶

¹Central Georgia Infectious Diseases, Macon, GA; ²Knoxville Infectious Disease Consultants, PC, Knoxville, TN; ³Austin Infectious Disease Consultants, Austin, TX; ⁴Atlanta ID Group, Atlanta, GA; ⁵Infectious Disease Associates, Sarasota, FL; ⁶Healix Infusion Therapy, Sugar Land, TX

#1625: Real-World Outpatient Utilization of Ceftolozane/Tazobactam in Physician Office Infusion Centers (OICs)

Lucinda J. Van Anglen, BS, PharmD¹, Ramesh V. Nathan, MD, FIDSA², Brian S. Metzger, MD, MPH³, Quyen Luu, MD⁴, Claudia P. Schroeder, PharmD, PhD¹

¹Healix Infusion Therapy, Sugar Land, TX; ²Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA; ³Austin Infectious Disease Consultants, Austin, TX; ⁴Central Georgia Infectious Diseases, Macon, GA

How can we help you?

Get in touch with us or learn more about our offerings.

“Our compounding agreement with Healix was the right decision to make to support our growing oncology service line. Healix’s expertise partnered with our commitment to quality and safety in patient care has made a positive difference.”

Hospital Director of Pharmacy
Houston Texas

“The Healix team has set the bar for professionalism, knowledge of the industry, and customer service that other companies typically fail to meet. Healix has made it a fun, effortless, and significant clinical enhancement for our patients!”

Pam Hamby
Infusion Program Director, The Allergy, Asthma, and Sinus Center Offices in Tennessee, Kentucky, & Georgia

"Establishing a relationship with Healix has allowed us to provide our patients with outstanding care while being able to control the clinical situation and achieve the best possible outcomes."

Andrew Krinsky, MD
Infectious Diseases Associates, Sarasota, Florida

“The Healix infusion business model works. Our collaborative team of physicians, an infusion nurse, and a clinical pharmacy hotline allows for real-time feedback and course correction if necessary. Healix has turned this small clinic into a real service for the community.”

Philip Blum, MD
MHS Physicians of Texas, Houston, Texas